SCHEMBL113706

SCHEMBL113706

O=CC(N1CCN(c2ccccc2-c2cnc(N3CCCCC3)nc2)CC1)n1ccc2cccnc21

nearest known ligand 0.33

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PTGS2 P35354 1/20 0.33
OGA O60502 4/20 0.32
FEN1 P39748 1/20 0.32
HTT P42858 4/20 0.32
ALDH1A1 P00352 3/20 0.32
TSHR P16473 3/20 0.32
SMN1; SMN2 Q16637 2/20 0.32
LMNA P02545 1/20 0.32
DHFR P00374 2/20 0.32
GAA P10253 1/20 0.32
PIM1 P11309 2/20 0.32
KDM4E B2RXH2 2/20 0.32
MEN1 O00255 2/20 0.32
KMT2A Q03164 2/20 0.32
MAPT P10636 1/20 0.32
CASP1 P29466 1/20 0.32
HBB P68871 1/20 0.32
PIM3 Q86V86 1/20 0.32
CNR2 P34972 1/20 0.31
IRAK4 Q9NWZ3 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL113717 0.91 CNR2 (0.39) FEN1ALDH1A1SMN1; SMN2MEN1KMT2A
SCHEMBL112867 0.87 DHFR (0.41) HTTALDH1A1TSHRLMNADHFR
SCHEMBL115691 0.87 SMN1; SMN2 (0.33) OGAALDH1A1SMN1; SMN2LMNAKDM4E
SCHEMBL113579 0.87 SMN1; SMN2 (0.33) OGAALDH1A1SMN1; SMN2LMNAKDM4E
SCHEMBL114800 0.86 DHFR (0.35) ALDH1A1TSHRDHFRGAACASP1
SCHEMBL113266 0.86 DHFR (0.35) HTTALDH1A1LMNADHFRGAA
SCHEMBL113518 0.83 ALDH1A1 (0.33) ALDH1A1DHFRGAACASP1DRD2
SCHEMBL113904 0.83 AOC3 (0.38) CNR2
SCHEMBL115569 0.82 HTR1A (0.38) OGAGAAHTR1AHTR7NPSR1
SCHEMBL15911247 0.82 SMO (0.34) OGAALDH1A1KDM4EIRAK4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2424840-A1 CXCR3 RECEPTOR ANTAGONISTS Boehringer Ingelheim International GmbH (DE) 2012-03-07 EP disclosed
WO-2010126811-A1 CXCR3 RECEPTOR ANTAGONISTS BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2010-11-04 WO disclosed